Marketplace®

Daily business news and economic stories

Steve Tripoli

Latest from Steve Tripoli

  • A new law makes turning in income tax cheaters far more profitable, earning informants up to 30 percent of what the IRS recovers. Tax experts think it's a win-win solution, Steve Tripoli reports.

    Read More
  • President Bush signed a big tax and trade bill today. Part of it made blowing the whistle on tax cheats far more profitable. Easier too. Steve Tripoli has the story.

    Read More
  • Starting a business is challenging under any circumstances, but try doing it amid deep poverty and a lack of know-how. Some folks on Indian reservations are — and they're succeeding. Steve Tripoli has the story.

    Read More
  • Shareholders of the New York Stock Exchange vote today on a merger with Euronext. If approved, the merger will create the first transatlantic exchange. Steve Tripoli looks at how it will affect investors.

    Read More
  • Franchises rake in $1 trillion in retail spending a year. One out of 16 Americans works in one. Franchise owners get name recognition and marketing clout from the home office. And that's not all. Steve Tripoli reports.

    Read More
  • A new wave of merger and acquisition announcements has been going on for months now, from biotech firms to auto parts makers. Steve Tripoli reports the shopping spree might go right past Christmas.

    Read More
  • Philip Morris is raising the price of its cigarettes by 10 cents a pack starting today. Steve Tripoli tells us how this one got passed on to consumers.

    Read More
  • The board of the world's largest casino company meets today to consider competing buyout offers from three private equity firms and a hedge fund. Steve Tripoli reports.

    Read More
  • More and more Native Americans are choosing entrepreneurship as a path out of poverty — and casinos aren't part of the mix, Steve Tripoli reports.

    Read More
  • Nov 29, 2006

    Celebrex for kids?

    An FDA commission today is expected to consider whether pain reliever Celebrex is suitable to treat juvenile rheumatoid arthritis. Steve Tripoli reports.

    Read More